Silk Road Medical Stock Current Valuation
| SILKDelisted Stock | USD 27.49 0.00 0.00% |
Valuation analysis of Silk Road Medical helps investors to measure Silk Road's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Silk Road's price fluctuation is very steady at this time. Calculation of the real value of Silk Road Medical is based on 3 months time horizon. Increasing Silk Road's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Silk Road's intrinsic value may or may not be the same as its current market price of 27.49, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.49 | Real 23.26 | Hype 27.49 |
The intrinsic value of Silk Road's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Silk Road's stock price.
Estimating the potential upside or downside of Silk Road Medical helps investors to forecast how Silk stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Silk Road more accurately as focusing exclusively on Silk Road's fundamentals will not take into account other important factors: Silk Road Medical Company Current Valuation Analysis
Silk Road's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Silk Road Current Valuation | 1.02 B |
Most of Silk Road's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Silk Road Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Silk Road Medical has a Current Valuation of 1.02 B. This is 92.88% lower than that of the Health Care Equipment & Supplies sector and 91.77% lower than that of the Health Care industry. The current valuation for all United States stocks is 93.85% higher than that of the company.
Silk Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silk Road's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Silk Road could also be used in its relative valuation, which is a method of valuing Silk Road by comparing valuation metrics of similar companies.Silk Road is currently under evaluation in current valuation category among its peers.
Silk Fundamentals
| Return On Equity | -0.36 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.34) % | |||
| Current Valuation | 1.02 B | |||
| Shares Outstanding | 40.63 M | |||
| Shares Owned By Insiders | 4.15 % | |||
| Shares Owned By Institutions | 97.46 % | |||
| Number Of Shares Shorted | 3.15 M | |||
| Price To Book | 7.22 X | |||
| Price To Sales | 5.83 X | |||
| Revenue | 177.13 M | |||
| Gross Profit | 100.76 M | |||
| EBITDA | (55.48 M) | |||
| Net Income | (55.74 M) | |||
| Cash And Equivalents | 108.87 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 84.63 M | |||
| Debt To Equity | 1.37 % | |||
| Current Ratio | 6.92 X | |||
| Book Value Per Share | 3.81 X | |||
| Cash Flow From Operations | (32.01 M) | |||
| Short Ratio | 2.48 X | |||
| Earnings Per Share | (1.45) X | |||
| Price To Earnings To Growth | (0.26) X | |||
| Target Price | 20.75 | |||
| Number Of Employees | 474 | |||
| Beta | 1.54 | |||
| Market Capitalization | 1.12 B | |||
| Total Asset | 265.31 M | |||
| Retained Earnings | (399.45 M) | |||
| Working Capital | 210.55 M | |||
| Net Asset | 265.31 M |
About Silk Road Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silk Road Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silk Road using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silk Road Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets |